Gain-of-function mutations in the tumor suppressor gene p53
- PMID: 10873062
Gain-of-function mutations in the tumor suppressor gene p53
Abstract
The tumor suppressor protein p53 is a multifunctional transcription factor involved in the control of cell cycle progression, DNA integrity, and cell survival. p53 is mutated in half of all tumors and has a wide spectrum of mutation types. p53 mutants show different degrees of dominance over coexpressed wild-type p53, and loss of the wild-type p53 allele has been observed frequently. Several p53 mutants can exert oncogenic functions beyond their negative domination over the wild-type p53 tumor suppressor functions. These so-called gain-of-function effects, such as enhancement of tumorigenicity and therapy resistance, were investigated in p53-null cells. The possible mechanisms by which p53 mutants exert their gain-of-function effects are reviewed. The existence of functional gains of certain p53 mutants has important ramifications for tumor prognosis and cancer therapies.
Similar articles
-
Mutant p53: gain-of-function oncoproteins and wild-type p53 inactivators.Biol Chem. 1999 Jul-Aug;380(7-8):879-87. doi: 10.1515/BC.1999.108. Biol Chem. 1999. PMID: 10494837 Review.
-
Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.Cancer Res. 2000 Dec 15;60(24):6788-93. Cancer Res. 2000. PMID: 11156366 Review.
-
The differential effects of mutant p53 alleles on advanced murine lung cancer.Cancer Res. 2005 Nov 15;65(22):10280-8. doi: 10.1158/0008-5472.CAN-05-2193. Cancer Res. 2005. PMID: 16288016
-
Tumour p53 mutations exhibit promoter selective dominance over wild type p53.Oncogene. 2002 Mar 7;21(11):1641-8. doi: 10.1038/sj.onc.1205250. Oncogene. 2002. PMID: 11896595
-
Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells.Cancer Res. 2003 Jun 1;63(11):2905-12. Cancer Res. 2003. PMID: 12782597
Cited by
-
Estimating dispensable content in the human interactome.Nat Commun. 2019 Jul 19;10(1):3205. doi: 10.1038/s41467-019-11180-2. Nat Commun. 2019. PMID: 31324802 Free PMC article.
-
Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.Mol Cancer. 2006 Oct 20;5:47. doi: 10.1186/1476-4598-5-47. Mol Cancer. 2006. PMID: 17054774 Free PMC article.
-
von Willebrand factor type D domain mutant of SVS-1/SUSD2, vWD(m), induces apoptosis in HeLa cells.Cancer Sci. 2007 Jun;98(6):909-15. doi: 10.1111/j.1349-7006.2007.00467.x. Epub 2007 Apr 12. Cancer Sci. 2007. PMID: 17428257 Free PMC article.
-
Expression of a mutant p53 results in an age-related demographic shift in spontaneous lung tumor formation in transgenic mice.PLoS One. 2009;4(5):e5563. doi: 10.1371/journal.pone.0005563. Epub 2009 May 15. PLoS One. 2009. PMID: 19440353 Free PMC article.
-
A naturally occurring p73 mutation in a p73-p53 double-mutant lung cancer cell line encodes p73 alpha protein with a dominant-negative function.Cancer Sci. 2003 Aug;94(8):718-24. doi: 10.1111/j.1349-7006.2003.tb01508.x. Cancer Sci. 2003. PMID: 12901798 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous